Insitro
Pricing Details
Operates on a partnership model with large pharmaceutical companies. Pricing model is based on collaboration agreements and potential payouts for successful outcomes (milestones, royalties).Features
Drug discovery, target identification, disease modeling, predictive toxicology, high-throughput data generation, machine learning in biology, genomics.Integrations
Deep integration with proprietary experimental platforms and data. Partnerships with pharmaceutical companies.Preview
Insitro is a biotechnology company that is applying machine learning and genetic data to fundamentally change the way drugs are discovered and developed. The company generates large and high-quality biological datasets through its own experimental platforms and then uses advanced machine learning models to identify novel drug targets, understand disease mechanisms, and predict the efficacy and safety of potential therapies. Insitro focuses on diseases where genetics play a key role, aiming to accelerate and improve the success rate of new drug development.